glucose, (beta-d)-isomer has been researched along with Endometrial Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, S; Ke, Y; Lin, R; Shi, Q; Shu, P; Wu, Z | 1 |
| Yang, L | 1 |
| Aligiannis, N; Chrousos, GP; Kassi, E; Mitakou, S; Moutsatsou, P; Papoutsi, Z; Tsiapara, A | 1 |
3 other study(ies) available for glucose, (beta-d)-isomer and Endometrial Neoplasms
| Article | Year |
|---|---|
Wogonoside inhibits tumor growth and metastasis in endometrial cancer via ER stress-Hippo signaling axis.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; Endoplasmic Reticulum Stress; Female; Flavanones; Glucosides; Hippo Signaling Pathway; Humans; Mice; Mice, Inbred BALB C; Protein Serine-Threonine Kinases; Scutellaria baicalensis | 2019 |
Physcion 8-O-β-glucopyranoside exerts carcinostasis ability in Ishikawa cells via regulating lnc-SLC4A1-1/H3K27ac/NF-κB pathway.
Topics: Anion Exchange Protein 1, Erythrocyte; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Emodin; Endometrial Neoplasms; Female; Glucosides; Humans; Molecular Targeted Therapy; Neoplasm Invasiveness; NF-kappa B; Transcription Factor RelA | 2020 |
Acteoside and martynoside exhibit estrogenic/antiestrogenic properties.
Topics: Breast Neoplasms; Calcinosis; Cell Survival; Endometrial Neoplasms; Estradiol Congeners; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Glucosides; HeLa Cells; Humans; Insulin-Like Growth Factor Binding Protein 3; Ligands; Osteoblasts; Phenols; Response Elements; Selective Estrogen Receptor Modulators; Transfection; Tumor Cells, Cultured | 2006 |